News

BUD beats Q2 EPS estimates on cost discipline and brand strength, but revenues miss amid soft China & Brazil volumes.
Stocks in a Bloodbath. Anheuser-Busch InBev SA/NV (NYSE:BUD) is one of the worst-performing stocks on Thursday.
Fintel reports that on August 1, 2025, HSBC downgraded their outlook for Ambev S.A. - Depositary Receipt () (NYSE:ABEV) from ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Analysts fell to the sidelines weighing in on TreeHouse Foods (THS – Research Report) and Procter & Gamble (PG – Research Report) with neutral ratings, indicating that the exp ...